Members M - R
M
MagForce Nanotechnologies AG
The Berlin based company is the global leader in the field of cancer treatment with nanotechnology. Through injection of magnetic nanoparticles directly into tumour tissue and subsequent heating in an alternating magnetic field solid tumours are destroyed from within. Currently, the technology is tested in clinical registration studies with glioblastoma and prostate cancer patients. Since September 2007 the company is listed at the Entry Standard of the Frankfurt Stock Exchange.
www.magforce.com
MAPO GmbH
Max-Planck-Innovation GmbH
Max-Planck-Innovation GmbH is the technology transfer agencyof the Max Planck Society (MPS). Max-Planck-Innovation organizes the transfer of new ideas and inventions to industrial products. Issuing licenses to innovative companies - especially to recent start-ups - contributes to the creation of new products and jobs.
www.max-planck-innovation.de/en/
Mayer Brown LLP
Mayer, Brown, Rowe & Maw LLP is an international law firm with more than 1.400 legal professionals in 14 offices, inter alia in Frankfurt am Main, Cologne and Berlin. Biotechnology, pharmaceuticals and the food industry as well as agribusiness – these indus-tries have always been in the forefront of the services we offer. We provide clients with com-prehensive legal advice in technology-specific issues.
In 2006, JUVE awarded Mayer, Brown, Rowe & Maw "Law firm of the Year" for Pharma and Medical devices law.
www.mayerbrown.com
MediGene AG
MediGene is the first German biotech company with a drug on the market. A second drug is about to enter the approval process. In addition, MediGene has several oncological drug candidates undergoing clinical development and possesses innovative platform technologies.
www.medigene.com
MerLion Pharmaceuticals GmbH
MerLion Pharmaceuticals Pte Ltd is a pharmaceutical company headquartered in Singapore, with clinical development operations based in Germany. The Company is focused on the discovery and development of innovative drug candidates aimed at addressing the increasing levels of bacterial and fungal resistance to existing therapies and thus, meet a growing medical need in both hospital and community settings.
www.merlionpharma.com
MicroDiscovery GmbH
MicroDiscovery is a leading provider of high quality software solutions in the areas of innovative in-vitro diagnostics, personalised medicine and biomolecular research.
The company has a distinct focus on the development of high quality software for in-vitro diagnostics especially on multiplex and multi-parameter applications. Our products meet the requirements of all relevant regulatory directives (97/98/EC, FDA CFR21 part 11) and quality standards (ISO 9001, ISO 13485).
www.microdiscovery.de
Micromet AG
MIG Verwaltungs AG
Mikrogen GmbH
Founded in 1989 MIKROGEN GmbH offers innovative solutions for medical laboratories. The company’s scope is the development and production of clinical diagnostic test systems based on recombinant antigens, with the focus on bacterial, viral, parasitic and autoimmune diseases. MIKROGEN’s core competencies covers genetic engineering and the scientific quality of research and development, which is reflected in various patent applications and publications in international journals. The key success factors of the company are the consequent customer orientation, the strong product competence and highly skilled employees.
www.mikrogen.de
Miltenyi Biotec GmbH
Miltenyi Biotec is a diversified biotechnology company providing state-of-the-art products and services to the life science and biomedical research community. Based on MACS® Technology, the gold standard in magnetic cell separation, the portfolio includes more than 750 products for the separation, cultivation, flow cytometric and molecular analysis of cells.
www.miltenyibiotec.com
MOLOGEN AG
MOLOGEN with headquarters in Berlin is a public company, developing vaccines and therapeutics for the treatment of infectious diseases and cancer. MOLOGEN has developed two proprietary technology platforms (MIDGE DNA vectors, dSLIM immunomodulators).
www.mologen.com
Momentum Pharma Services GmbH
Momentum Pharma Services GmbH is one of the leading contract research organisations (CRO) in the northern part of Germany. Our 72-bed clinic is focused in clinical trials of phase I and II conducted with volunteers and/or patients. Our unit is highly experienced in offering clinical service to the pharmaceutical and biotechnological industry. Our service range includes studies like First-In-Man, Proof-Of-Concept, Dose-Ranging, Drug-drug interaction, Pharmacodynamic, PK (bioequivalence, biovailability and interaction) and long-term confinements. We have experience with trials on diabetes, sleep disorder, arthritis, Alzheimer, gastrointestinal diseases, vaccination, special population (postmeno, elderly), nicotine replacement and food (e.g. fatty acids). We are focused on high quality and itensive contact to the customer. Our company has efficient overheads, allowing us to offer an integrated, modular approach at better value for money proposals than the competition.
www.momentum-ps.de
MorphoSys AG
MorphoSys is one of the world"s leading biotechnology companies focusing on fully human antibodies. With its proprietary technologies, MorphoSys is developing not only the next generation of therapeutic antibodies, but also antibodies for research and diagnostics purposes.
www.morphosys.com
N
NascaCell Technologies AG
NascaCell is a global leader in the automated production and marketing of custom aptamers for target validation and drug discovery, opening new ways beyond antibodies, RNAi and other technologies. NascaCell also develops Microbodies™, extremely stable new protein therapeutics with small molecule characteristics.
www.nascacell.de
NewLab BioQuality AG
Nexigen GmbH
Nexigen GmbH develops highly specific drugs with less unwanted side effects and a novel mode of action. The company focuses on peptide-derived drugs for anti-viral, but also other indications. In addition to the own drug discovery projects Nexigen has been active in pharma and biotech cooperations and successfully finalized all of them (e.g. with Bayer-Schering, Johnson & Johnson PRD and others).
Nexigen developed a proprietary, novel technology platform, which can be widely applied. The integrated platform relies on cellular screening systems for target screening and for the identification of peptide modulators.
In April 2008 Nexigen closed an investment round involving Santo Holding (Strüngmann) and 4SC AG. Nexigen currently employs 10 people and is located in Bonn, Germany.
www.nexigen.de
NMI
norgenta GmbH
Norgenta North German Life Science Agency is the service provider for the life sciences in Hamburg and Schleswig-Holstein. Under the common brand name Life Science Nord it supports, networks and coordinates life science activities in North Germany for an internationally competitive cluster.
www.norgenta.de
Novaliq GmbH
Novaliq GmbH is a medical technology / biopharmaceutical company with the aim to develop and market life-saving drug delivery systems for the treatment of severe lung diseases, such as for example acute respiratory distress syndrome (ARDS). The so-called semifluorinated alkanes (SFA) used for this purpose can equally be developed and used as carrier fluid or aerosol for the transport of pharmaceutical drugs. Thus, SFA can deposit drugs in the lungs or getting via the lungs directly into the bloodstream for the treatment of diverse diseases in a highly efficient manner. Furthermore, SFA are suitable for the production of long-term stable synthetic oxygen carriers (blood substitutes), gas permeable gels for wound covering, as well as a medium for the preservation of organs.
www.novaliq.de
novosom AG
Novosom AG is a biopharmaceutical company which has solved the major obstacle towards oligonucleotide therapeutics with the discovery of the Smarticles technology: Delivery of the oligonucleotides towards the cell interior. Smarticles are establishing themselves as an enabling technology for oligonucleotide systemic therapies. Novosom and its partners develop unique antisense and siRNA therapeutics in inflammation, autoimmune, oncology and liver diseases.
www.novosom.com
NOXXON Pharma AG
NOXXON Pharma AG is a biotech company focusing on the rapid development of innovative pharmaceuticals based on its unique Spiegelmer technology. Spiegelmers are outstanding biostable aptamers that can be designed to block peptide-protein or protein-protein interactions.
www.noxxon.net
Nycomed GmbH
O
Oncotest GmbH
Organo Balance GmbH
The best trained scientists in the fields of medicine, biotechnology and microbiology research work together at OrganoBalance with experienced professionals in the management area. The position of managing director of the company, which was founded in 2001 with headquarters in Berlin, is held by Dr. Christine Lang
www.organobalance.de
P
PAION AG
PAION, a biopharmaceutical company based in Aachen, Germany, aims to become a leader in developing and commercialising innovative drugs for thetreatment of stroke and other thrombotic diseases for which there is a substantial unmet medical need.
www.paion.de
PANATecs GmbH
PANATecs GmbH is a Service Company offering complex peptide synthesis services and comprehensive mass spectrometry-based analytical services for peptides, proteins and biosimilars – extended characterisation, biocomparability analysis, etc. In addition we are synthesis specialists for complex peptides up to 80aa in a range of 1 to more than 100mg.
www.panatecs.com
pervormance GmbH
pervormance(R) is the innovative service provider for the biotechnology, pharmaceutical and life-sciences sectors. The strength of the company lies in the translation and implementation of product ideas into market success. The client's size is not important. pervormance is interested in the product and ensures that it can be successfully placed on the market - either through the customer sales organization, in cooperation with other companies or through external sales organizations. For this, the rapid transformation of research results into practical applications and their professional marketing are absolutely necessary. pervormance works with specialists for technology transfer, product development, business development and sales and marketing. The team for personnel and organization ensures that the right employees are in the right place at the right time.
www.pervormance.com
Peters, Schönberger und Partner GbR
PSP is a multidisciplinary firm giving advice to national and international companies, entrepreneurs and wealthy individuals on legal, tax and audit matters specializing on transactions, corporate, technology transfer and compliance. In these fields, our auditors, tax advisors and lawyers work closely together for your benefit so that you get comprehensive advice with a clear business focus. We have extensive experience in complex equity and non-equity transactions involving technology transfer as well as in M&A, Management Buy Out, Private Equity and Venture Capital transactions. We can either run or supervise the project management of your transaction so that you can continue to focus on your business, even during important transactions.
www.pspmuc.de
PharmaLex GmbH
PharmaLex International provides specialized support for drug registrations, enabling registration to be as rapid and uncomplicated as possible in Europe, the US or Asia.
Depending upon the specific requirements, PharmaLex’s highly qualified registration experts can assist in all areas, e.g. evaluate the documents in view of current rules and guidelines, compile a complete electronic dossier, and manage the entire process. Our expertise includes medicinal products, such as NCEs, generics, biotechnological products, phytotherapeutics, as well as medical devices, food supplements and cosmetics. PharmaLex international can manage either parts or the whole of your registration process. Mutual Recognition Procedures in the EU (MRP, DCP), National registrations, Centralised Procedures (CP), DMF and CEP processes, CTAs, Variations and Renewals. For EU registrations PharmaLex’s network of local offices and partners ensure a trouble-free registration.
www.pharmalex.de
Pharmexx GmbH
pharmexx is one of the leading contract sales and marketing organisations (CSMO) world-wide which takes over tasks in the sales, marketing and distribution areas for pharmaceutical companies.
pharmexx is represented in 23 countries by subsidiaries which offer innovative solutions for 48 markets. Where pharmexx itself is not present we work closely with alliance partners who ensure quality services in further markets. More than 5,000 sales staff involved in successfully marketing innovative products world-wide. In Europe pharmexx counts among the fastest growing companies and since 2006 is the largest CSO.
www.pharmexx.com
Phenex Pharmaceuticals AG
Phenex AG focuses on drug discovery on nuclear receptors with Diabetes and Hyperlipidemias as key indications of our own research. Moreover, Phenex offers a wide array of nuclear receptor assays (27 human NRs) and the “SNuRM”-technology for guided optimisation of compounds towards an improved therapeutic ratio on a fee-for-service basis.
www.phenex-pharma.com
PIERIS AG
PKCie - Prof. Köpper & Cie Management Consultants
Our company provides support in the search of top executives and in the evaluation of mangement teams for firms in Life Sciences, Healthcare, Chemistry, HiTech, and Com-IT. We work in these industries solely since we consider the consultant’s experience and expertise in the client’s sector indispensable.
It is our deliberate policy to be „small but nice“ which allows us to provide our clients with exclusive and fully personal services. We act trans- and internationally from Frankfurt am Main, and we work closely together with our executive search partner in California.
www.pk-cie.com
PP PHARMA PLANING Unternehmensberatung GmbH
PP PHARMA PLANING is a German / Swiss retainer based Executive Search Consulting Company for International Recruitment of Executives, Directors and Specialists in Health Care / Pharma / BioTech / MedTech.
www.pp-pharma-planing.de
PricewaterhouseCoopers AG
With some 8,400 employees and a turnover of around 1.35 billion euros, PricewaterhouseCoopers AG Wirtschaftsprüfungsgesellschaft is one of the leading auditing and consultancy companies in Germany. Experts at 28 locations work on behalf of national and international clients of every size. The focus is on assurance and business advisory services, tax services as well as transaction services and consulting. In Germany, our Competence Team Pharma and Life Sciences initiates and coordinates industry-specific solutions for the future.
www.pwc.de
probiodrug AG
Probiodrug AG, a drug development company, creates novel concepts in modifying neuropeptide and hormone regulation.
Probiodrug"s pipeline includes research and development programs directed towards the treatment of Age Related Disorders for the therapeutic fields of Metabolism, CNS and Autoimmunity.
www.probiodrug.de
ProBioGen AG
ProBioGen AG, Berlin, Germany, is a contract organisation in cell line design and manufacturing of biologicals. The Company offers a wide spectrum of services to support the biopharmaceutical industry, including the creation of designer cell lines, the development of high-producer cell lines, generation of viral vectors, and production of bulk protein for R&D, in vitro diagnostics, and clinical trials; and through its subsidiary to supply the market.
www.probiogen.de
Profos AG
Innovative binding molecules on the basis of bacterial viruses are at the centre of attention of Profos AG, which was set up in Regensburg in 2000. Besides other areas of application the technology is used in food quality monitoring for the reliable detection of pathogenic germs or in pharmaceutical research for the detection and removal of fever-inducing endotoxins. Only recently Profos received 5 million euros new capital in the first part of the current series of financing.
www.profos.de
Protagen AG
Protagen AG is counted among the world"s leading biotechnolgy companies. The company, established in 1997, translates the latest technologies in applied proteomics, protein biochips and bioinformatics into products from which the entire life science industry and research institutes can profit.
www.protagen.de
Proteros biostructures GmbH
Proteros biostructures GmbH, Martinsried, is Europe’s most experienced and largest company focusing on X-ray protein structure analysis. Successful in business since 1998, Proteros collaborates now with more than 40 renowned pharmaceutical, biotechnology and agrochemical companies.
Proteros offers excellent expertise and innovative platform technologies to improve its customer’s productivity of structure-based drug discovery. Proteros’ competitive advantage is the proven capability of producing high-resolution X-ray data and protein-ligand-complexes using its industrialized process and proprietary technologies, and large catalogue of Gallery Structures.
www.proteros.com
Provendis GmbH
The marketing of patent-protected cutting edge technology to industry is our core task. Our aim is to reap the full economic benefits of the innovative potential of universities and research institutes through knowledge transfers to companies. PROvendis GmbH forms an important link between universities and industry. We bring the two sides together in a professional context, thereby promoting cooperation.
PROvendis acts as a service provider for 24 universities and other public research institutes in the state of North Rhine-Westphalia, Germany. We offer companies exclusive access to the inventions and patents of over 20,000 scientists from a diverse range of technological fields. Our many contacts – which range from medium-sized regional firms to global players – and cooperation with other exploitation partners enable us to efficiently commercialise technology.
www.provendis.info
Q
Qiagen GmbH
QIAGEN N.V is the world"s leading provider of sample and assay technologies. The portfolio comprises more than 500 products for the isolation and preparation of nucleic acids and proteins as well as molecular tests. These are sold to customers in academic and industrial research, applied testing (such as forensics) as well as to molecular diagnostics laboratories. QIAGEN employs more than 1,950 people worldwide.
www.qiagen.com
R
Ray & Berndtson Unternehmensberatung GmbH
Ray & Berndtson is a worldwide operating executive search firm. With 51 offices and more than 150 partners, Ray & Berndtson is presented in all major global markets. In Germany, more than 100 staff members are working in offices in Frankfurt, Munich, and Hamburg.
The Ray & Berndtson competence center Healthcare/Life Science assists its client in the search and hiring of qualified executives and experts and in assessing the future potential of executives as part of a management audit (Human Asset Review).
www.ray-berndtson.de
RESprotect GmbH
RESprotect GmbH from Dresden develops drugs that prevent induction of chemoresistance of tumor cells and enhance their chemosensitivity. This concept is worldwide without concurrence. The first drug RP101 significantly extended survival time of pancreas cancer patients in a clinical pilot study.
www.resprotect.de
Revotar Biopharmaceuticals AG
Revotar develops innovative small molecule drugs (SMD) for the treatment ofchronic inflammatory disorders such as asthma, chronic obstructive pulmonary disease (COPD) and psoriasis as well as other inflammatory diseases. With its drug candidate bimosiamose, Revotar has the worldwide most advanced pan-selectin-antagonist in clinical development in its product pipeline. Revotar"s leading product is bimosiamose for which Revotar owns the worldwide exclusive rights. Bimosiamose passedalready several preclinical animal models as well as clinical phase I and phase IIa trials in asthma and psoriasis. Furthermore, Revotar runs a "state of the art" laboratory for identifying potential future drug candidates ("Drug Discovery") and a drug development department. Our second generation of pan selection antagonist is in the stage of lead optimization.
www.revotar-ag.de
Rhein Biotech GmbH
Richter-Helm BioTec GmbH & Co. KG
Richter-Helm is a dynamic and expanding biotechnology company located in Hamburg, Germany. The company was founded in 1997 as Strathmann Biotec and was acquired by a joint-venture of Gedeon Richter Plc, Hungary and Helm AG, Germany in 2007.
Richter-Helm offers:
Contract development and manufacturing of recombinant proteins, plasmid DNA (industrial scale) and microbial vaccines according to cGMP, full development up to finished product and global in- and out-licensing of biopharmaceutical projects.
www.richter-helm.eu
Rittershaus Rechtsanwälte Notar
Roche Kulmbach
www.roche-kulmbach.de
Roche Kulmbach GmbH is Roche's Center of Excellence for the discovery and development of RNA Therapeutics. Currently the team focuses on a new class of therapeutics based on the principle of RNA interference (RNAi) which is a natural process mediated by Small Interfering RNAs (siRNAs) to selectively silence endogenous genes. Roche Kulmbach GmbH uses synthetic siRNAs to specifically silence disease-associated genes. This universal approach is applied to develop novel therapeutics for the treatment of oncological, respiratory and metabolic diseases.